Jubilant Pharmova Roorkee facility gets 6 USFDA observations

Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has recently concluded audit of the Solid Dosage Formulations facility at Roorkee, India of Jubilant Generics, a subsidiary of its wholly owned subsidiary Jubilant Pharma Limited.

The USFDA has issued six observations pursuant to the completion of the audit.

For more details, check out the full story on the link below:

USFDA Issues 6 Observations For Jubilant Pharmova Roorkee Facility